These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 174310)

  • 1. [Estrogen receptors in human and animal mammary gland tumors].
    El'tsina NV
    Vopr Onkol; 1975; 21(5):118-26. PubMed ID: 174310
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of estrogen receptors in human breast cancer.
    Olsnes S; Pihl A
    Biomedicine; 1974 Nov; 20(6):377-83. PubMed ID: 4376029
    [No Abstract]   [Full Text] [Related]  

  • 3. Early stages in estrogen control of gene expression and its derangement in cancer.
    Bresciani F; Nola E; Sica V; Puca GA
    Fed Proc; 1973 Nov; 32(11):2126-32. PubMed ID: 4359599
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of o,p'-DDT with the estrogen-binding protein (EBP) of DMBA-induced rat mammary tumors.
    Mason RR; Schulte GJ
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):119-28. PubMed ID: 6791254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of malignant breast tumors containing estrogen receptors].
    El'tsina NV
    Vopr Onkol; 1982; 28(4):95-102. PubMed ID: 7046238
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgen effects mediated by estrogen receptor in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Garcia M; Rochefort H
    Cancer Res; 1978 Nov; 38(11 Pt 1):3922-9. PubMed ID: 100211
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid-binding proteins of the mammary gland and their clinical significance in breast cancer.
    Wittliff JL; Mehta RG; Boyd PA; Goral JE
    J Toxicol Environ Health Suppl; 1976; 1():231-56. PubMed ID: 186628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptors and breast cancer response to adrenalectomy.
    Jensen EV; Block GE; Smith S; Kyser K; DeSombre ER
    Natl Cancer Inst Monogr; 1971 Dec; 34():55-70. PubMed ID: 5140877
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone dependence and estradiol receptors in the D series of mammary nodule outgrowth lines and tumors.
    Medina D; Iramain CA; Clark JH
    Cancer Res; 1975 Sep; 35(9):2355-69. PubMed ID: 167955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation.
    DeSombre ER; Kledzik G; Marshall S; Meites J
    Cancer Res; 1976 Feb; 36(2 Pt 1):354-8. PubMed ID: 177195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
    Bodwin JS; Clair T; Cho-Chung YS
    Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL; Katzenellenbogen BS
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors.
    Yoshida H; Fukuhara T; Yamashi S; Yoshida A; Fukunishi R; Tsuji M; Matsumoto K
    Cancer Res; 1983 May; 43(5):2311-6. PubMed ID: 6403234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of binding to estrogen, androgen, progestin, and glucocorticoid receptors in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and their hormonal control.
    Asselin J; Melançon R; Moachon G; Bélanger A
    Cancer Res; 1980 May; 40(5):1612-22. PubMed ID: 6768450
    [No Abstract]   [Full Text] [Related]  

  • 15. [Estrogen dependence of mammary gland tumors: the mechanisms of the disorder and the evaluation criteria].
    Merkulova TI; Morozova TM; Sakganik RI
    Vopr Onkol; 1980; 26(10):67-75. PubMed ID: 7434681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptors in androgen-induced breast tumor regression.
    Zava DT; McGuire WL
    Cancer Res; 1977 Jun; 37(6):1608-10. PubMed ID: 192456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol binding to nuclear receptors in human breast cancer tissue (MCF-7 cell line) and in dimethylbenz(a)anthracene-induced mammary carcinoma.
    Geier A; Cocos M; Ginzburg R; Haimsohn M; Lunenfeld B
    J Clin Endocrinol Metab; 1979 Jul; 49(1):34-9. PubMed ID: 109464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin and estrogen binding in transplantable hormone-dependent and autonomous rat mammary carcinoma.
    Costlow ME; Buschow RA; Richert NJ; McGuire WL
    Cancer Res; 1975 Apr; 35(4):970-4. PubMed ID: 163700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.